Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis.

Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM, Li Y, Nelson RA, Mu B, Onami SH, Wu JJ, Ruel NH, Wilczynski SP, Gao H, Covarrubias M, Figlin RA, Weiss LM, Wu H.

PLoS One. 2012;7(5):e35661. doi: 10.1371/journal.pone.0035661. Epub 2012 May 18.

2.

Profiling microRNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma.

Kowalik CG, Palmer DA, Sullivan TB, Teebagy PA, Dugan JM, Libertino JA, Burks EJ, Canes D, Rieger-Christ KM.

BJU Int. 2017 Sep;120(3):428-440. doi: 10.1111/bju.13886. Epub 2017 May 18.

PMID:
28432832
3.

MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.

Heinzelmann J, Unrein A, Wickmann U, Baumgart S, Stapf M, Szendroi A, Grimm MO, Gajda MR, Wunderlich H, Junker K.

Ann Surg Oncol. 2014 Mar;21(3):1046-54. doi: 10.1245/s10434-013-3361-3. Epub 2013 Nov 18.

PMID:
24242678
4.

miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.

White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, Evans AJ, Gabril M, Yousef GM.

Br J Cancer. 2011 Nov 22;105(11):1741-9. doi: 10.1038/bjc.2011.401. Epub 2011 Oct 27.

5.

MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.

Nofech-Mozes R, Khella HW, Scorilas A, Youssef L, Krylov SN, Lianidou E, Sidiropoulos KG, Gabril M, Evans A, Yousef GM.

Cancer Med. 2016 Apr;5(4):656-64. doi: 10.1002/cam4.631. Epub 2016 Feb 10.

6.

miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.

Chen X, Ruan A, Wang X, Han W, Wang R, Lou N, Ruan H, Qiu B, Yang H, Zhang X.

J Cancer Res Clin Oncol. 2014 Aug;140(8):1295-304. doi: 10.1007/s00432-014-1690-7. Epub 2014 May 7.

PMID:
24802708
7.

Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.

Wotschofsky Z, Gummlich L, Liep J, Stephan C, Kilic E, Jung K, Billaud JN, Meyer HA.

PLoS One. 2016 Feb 9;11(2):e0148746. doi: 10.1371/journal.pone.0148746. eCollection 2016.

8.

The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.

Fritz HK, Lindgren D, Ljungberg B, Axelson H, Dahlbäck B.

Eur J Cancer. 2014 Jul;50(10):1758-65. doi: 10.1016/j.ejca.2014.03.281. Epub 2014 Apr 30.

PMID:
24793999
9.

Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma.

Heinzelmann J, Henning B, Sanjmyatav J, Posorski N, Steiner T, Wunderlich H, Gajda MR, Junker K.

World J Urol. 2011 Jun;29(3):367-73. doi: 10.1007/s00345-010-0633-4. Epub 2011 Jan 13.

PMID:
21229250
10.
11.

A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma.

Ge YZ, Wu R, Xin H, Zhu M, Lu TZ, Liu H, Xu Z, Yu P, Zhao YC, Li MH, Hu ZK, Zhao Y, Zhong B, Xu X, Zhou LH, Xu LW, Wu JP, Li WC, Zhu JG, Jia RP.

J Cancer Res Clin Oncol. 2015 Jul;141(7):1291-9. doi: 10.1007/s00432-015-1927-0. Epub 2015 Jan 30.

PMID:
25633718
12.

A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.

Hanniford D, Zhong J, Koetz L, Gaziel-Sovran A, Lackaye DJ, Shang S, Pavlick A, Shapiro R, Berman R, Darvishian F, Shao Y, Osman I, Hernando E.

Clin Cancer Res. 2015 Nov 1;21(21):4903-12. doi: 10.1158/1078-0432.CCR-14-2566. Epub 2015 Jun 18.

13.

Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.

Liep J, Kilic E, Meyer HA, Busch J, Jung K, Rabien A.

PLoS One. 2016 Jun 23;11(6):e0157801. doi: 10.1371/journal.pone.0157801. eCollection 2016.

14.

SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis.

Kowalczyk AE, Krazinski BE, Godlewski J, Grzegrzolka J, Kiewisz J, Kwiatkowski P, Sliwinska-Jewsiewicka A, Dziegiel P, Kmiec Z.

Cancer Genomics Proteomics. 2016 May-Jun;13(3):209-17.

PMID:
27107063
15.

Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).

Li W, Liu M, Feng Y, Xu YF, Huang YF, Che JP, Wang GC, Yao XD, Zheng JH.

Br J Cancer. 2014 Sep 9;111(6):1188-200. doi: 10.1038/bjc.2014.382. Epub 2014 Jul 10.

16.

Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.

Slaby O, Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R, Svoboda M, Vyzula R.

Genes Chromosomes Cancer. 2012 Jul;51(7):707-16. doi: 10.1002/gcc.21957. Epub 2012 Apr 10.

PMID:
22492545
17.

Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.

Hur K, Toiyama Y, Schetter AJ, Okugawa Y, Harris CC, Boland CR, Goel A.

J Natl Cancer Inst. 2015 Feb 6;107(3). pii: dju492. doi: 10.1093/jnci/dju492. Print 2015 Mar.

18.

A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.

Liu N, Cui RX, Sun Y, Guo R, Mao YP, Tang LL, Jiang W, Liu X, Cheng YK, He QM, Cho WC, Liu LZ, Li L, Ma J.

Int J Cancer. 2014 Mar 15;134(6):1359-68. doi: 10.1002/ijc.28468. Epub 2013 Sep 30.

19.

Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava.

Vergho DC, Kneitz S, Kalogirou C, Burger M, Krebs M, Rosenwald A, Spahn M, Löser A, Kocot A, Riedmiller H, Kneitz B.

PLoS One. 2014 Oct 3;9(10):e109877. doi: 10.1371/journal.pone.0109877. eCollection 2014.

20.

Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas.

Wotschofsky Z, Liep J, Meyer HA, Jung M, Wagner I, Disch AC, Schaser KD, Melcher I, Kilic E, Busch J, Weikert S, Miller K, Erbersdobler A, Mollenkopf HJ, Jung K.

Int J Biol Sci. 2012;8(10):1363-74. doi: 10.7150/ijbs.5106. Epub 2012 Oct 28.

Supplemental Content

Support Center